Squarepoint’s Clovis Oncology, Inc. CLVS Stock Holding History

Squarepoint’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,700	Closed	-$20K	–	3750
2022 Q3	$20K	Sell	16,700 -23,658	-59%	-$36.9K	﹤0.01%	2912
2022 Q2	$73K	Sell	40,358 -215,383	-84%	-$318K	﹤0.01%	2672
2022 Q1	$517K	Buy	255,741 +193,245	+309%	+$380K	﹤0.01%	1989
2021 Q4	$169K	Sell	62,496 -88,595	-59%	-$328K	﹤0.01%	2773
2021 Q3	$674K	Buy	151,091 +6,022	+4%	+$29K	﹤0.01%	1797
2021 Q2	$841K	Buy	145,069 +74,148	+105%	+$434K	﹤0.01%	1764
2021 Q1	$498K	Sell	70,921 -41,936	-37%	-$281K	﹤0.01%	2023
2020 Q4	$542K	Buy	+112,857	New	+$571K	﹤0.01%	1759
2020 Q2	–	Sell	-43,908	Closed	-$279K	–	2613
2020 Q1	$279K	Sell	43,908 -31,827	-42%	-$255K	0.01%	1328
2019 Q4	$790K	Sell	75,735 -217,109	-74%	-$1.58M	﹤0.01%	1484
2019 Q3	$1.15M	Buy	292,844 +251,881	+615%	+$2.04M	0.01%	1135
2019 Q2	$609K	Buy	40,963 +10,044	+32%	+$181K	0.01%	1547
2019 Q1	$767K	Sell	30,919 -48,066	-61%	-$1.2M	0.01%	1239
2018 Q4	$1.42M	Buy	78,985 +72,116	+1,050%	+$1.47M	0.02%	798
2018 Q3	$202K	Sell	6,869 -33,467	-83%	-$1.3M	﹤0.01%	1770
2018 Q2	$1.83M	Buy	40,336 +34,136	+551%	+$1.66M	0.02%	668
2018 Q1	$327K	Sell	6,200 -4,293	-41%	-$250K	0.01%	1277
2017 Q4	$714K	Buy	+10,493	New	+$734K	0.01%	987
2017 Q3	–	Sell	-2,700	Closed	-$253K	–	1966
2017 Q2	$253K	Buy	+2,700	New	+$165K	0.01%	1211
2017 Q1	–	Sell	-20,813	Closed	-$925K	–	2016
2016 Q4	$925K	Buy	20,813 +13,813	+197%	+$486K	0.04%	540
2016 Q3	$252K	Buy	+7,000	New	+$150K	0.02%	806
2016 Q1	–	Sell	-16,000	Closed	-$560K	–	1525
2015 Q4	$560K	Buy	+16,000	New	+$1.03M	0.06%	477

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Squarepoint's CLVS Position: Q4 2022 in Review

Squarepoint sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 16,700 shares — an estimated $20K sold.

Squarepoint first reported a position in CLVS in Q4 2015 and held it in 22 quarters. The position peaked at $1.83M in Q2 2018. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Squarepoint reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Squarepoint sold 16,700 Clovis Oncology, Inc. shares in Q4 2022, an estimated $20K.
Squarepoint first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 22 quarters.
Squarepoint's Clovis Oncology, Inc. position peaked at $1.83M in Q2 2018.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Squarepoint's 13F filing for Q4 2022, filed 14 Feb 2023.